Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2025-12-31 @ 10:09 PM
Study NCT ID:
NCT00426556
Status:
COMPLETED
Last Update Posted:
2015-12-28
First Post:
2007-01-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-07
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-23
First Submit QC Date:
None
Study First Post Date:
2007-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-20
Results First Submit QC Date:
None
Results First Post Date:
2015-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-11-24
Last Update Post Date:
2015-12-28
Last Update Post Date Type:
ESTIMATED